[1] Kalra, S.S. and Shanahan, C.M. (2012) Vascular Calcification and Hypertension: Cause and Effect. Annals of Medicine, 44, S85-S92.
http://dx.doi.org/10.3109/07853890.2012.660498
[2] Geleijnse, J.M., Vermeer, C., Grobbee, D.E., Schurgers, L.J., Knapen, M.H.J., van der Meer, I.M., et al. (2004) Dietary Intake of Menaquinone Is Associated with a Reduced Risk of Coronary Heart Disease: The Rotterdam Study. Journal of Nutrition, 134, 3100-3105.
[3] Beulens, J.W.J., Bots, M.L., Atsma, F., Bartelink, M.-A.E.L., Prokop, M., Geleijnse, J.M., et al. (2008) High Dietary Menaquinone Intake Is Associated with Reduced Coronary Calcification. Atherosclerosis, 203, 489-493.
http://dx.doi.org/10.1016/j.atherosclerosis.2008.07.010
[4] Gast, G.C.M., de Roos, N.M., Bots, M.L., Beulens, J.W.J., Geleijnse, J.M., Witteman, J.C., et al. (2009) High Menaquinone Intake Reduces the Incidence of Coronary Heart Disease. Nutrition, Metabolism and Cardiovascular Diseases, 19, 504-507.
http://dx.doi.org/10.1016/j.numecd.2008.10.004
[5] Price, P.A., Faus, S.A. and Williamson, M.K. (1998) Warfarin Causes Rapid Calcification of the Elastic Lamellae in Rat Arteries Heart Valves. Arteriosclerosis, Thrombosis, and Vascular Biology, 18, 1400-1407.
http://dx.doi.org/10.1161/01.ATV.18.9.1400
[6] Howe, A.M. and Webster, W.S. (2000) Warfarin Exposure and Calcification of the Arterial System of the Rat. International Journal of Experimental Pathology, 81, 51-56.
http://dx.doi.org/10.1046/j.1365-2613.2000.00140.x
[7] Spronk, H.M.H., Soute, B.A.M., Schungers, L.J., Thijssen, H.H.W., DeMey, J.G.R. and Vermeer, C. (2003) Tissue-Specific Utilization of Menaquinone-4 Results in the Prevention of Arterial Calcification in Warfarin-Treated Rats. Journal of Vascular Research, 40, 531-537.
http://dx.doi.org/10.1159/000075344
[8] Schungers, L.J., Spronk, H.M.H., Soute, B.A.M., Schiffers, P.M., DeMey, J.G.R. and Vermeer, C. (2007) Regression of Warfarin-Induced Medial Elastocalcinosis by High Inkake of Vitamin K in Rats. Blood, 109, 2823-2831.
[9] Dao, H.H., Essalihi, R., Graillon, J.-F., Lariviere, R., de Champlain, J. and Moreau, P. (2002) Pharmacological Prevention and Regression of Arterial Remodeling in a Rat Model of Isolated Systolic Hypertension. Journal of Hypertension, 20, 1597-1606.
http://dx.doi.org/10.1097/00004872-200208000-00023
[10] Essalihi, R., Zandvliet, M.L., Moreau, S., Gilbert, L.-A., Bouvet, C., Lenoel, C., et al. (2007) Distinct Effects of Amlopidine Treatment on Vascular Elastocalcinosis and Stiffness in a Rat Model of Isolated Systolic Hypertension. Journal of Hypertension, 25, 1879-1886.
http://dx.doi.org/10.1097/HJH.0b013e328255e906
[11] Liu, C.Y., Wan, J.J., Yang, Q.F., Qi, B.L., Peng, W. and Chen, X.L. (2008) Effects of Atorvastatin on Warfarin-Induced Aortic Medial Calcification and Systolic Blood Pressure in Rats. Journal of Huazhong University of Science and Technology, 28, 535-538.
http://dx.doi.org/10.1007/s11596-008-0510-1
[12] Beazley, K.E., Banyard, D., Lima, F., Deasey, S.C., Nurminsky, D.I., Komoplyannikov, M. and Nurminskaya, M.V. (2013) Transglutaminase Inhibitors Attenuate Vascular Calcification in a Preclinical Model. Arteriosclerosis, Thrombosis, and Vascular Biology, 33, 43-51.
http://dx.doi.org/10.1161/ATVBAHA.112.300260
[13] Ferland, G. (1998) The Vitamin K-Dependent Proteins: An Update. Nutrition Reviews, 56, 223-230.
http://dx.doi.org/10.1111/j.1753-4887.1998.tb01753.x
[14] Luo, G., Ducy, P., McKee, M.G., Pinero, G.J., Loyer, E., Behringer, R.R. and Karsenty, G. (1998) Spontaneous Calcification of Arteries and Cartilage in Mice Lacking Matrix GLA Protein. Nature, 386, 78-81.
http://dx.doi.org/10.1038/386078a0
[15] Danziger, J. (2008) Vitamin K-Dependent Proteins, Warfarin, and Vascular Calcification. Clinical Journal of the American Society of Nephrology, 3, 1504-1510.
http://dx.doi.org/10.2215/CJN.00770208
[16] Erkkilä, A.T. and Booth, S.L. (2008) Vitamin K Intake and Atherosclerosis. Current Opinion in Lipidology, 19, 39-42.
http://dx.doi.org/10.1097/MOL.0b013e3282f1c57f
[17] Essalihi, R., Dao, H.H., Yamaguchi, N. and Moreau, P. (2003) A New Model of Isolated Systolic Hypertension Induced by Chronic Warfarin and Vitamin K1 Treatment. American Journal of Hypertension, 16, 103-110.
http://dx.doi.org/10.1016/S0895-7061(02)03204-1
[18] Lomashvili, K.A., Cobbs, S., Hennigar, R.A., Hardcastle, K.I. and O’Neill, W.C. (2004) Phosphate-Induced Vascular Calcification: Role of Pyrophosphate and Osteopontin. Journal of the American Society of Nephrology, 15, 1392-1401.
http://dx.doi.org/10.1097/01.ASN.0000128955.83129.9C
[19] Schibler, D., Russell, G.G. and Fleisch, H. (1968) Inhibition by Pyrophosphate and Polyphosphate of Aortic Calcification Induced by Vitamin D3 in Rats. Clinical Science, 35, 363-372.
[20] Boehm, O., Zu, B., Koch, A., Tran, N., Freyenhagen, R., Hartmann, M. and Zacharowski, K. (2007) Clinical Chemistry Reference Database for Wistar Rats and C57/BL6 Mice. Biological Chemistry, 388, 547-554.
http://dx.doi.org/10.1515/BC.2007.061
[21] Zhu, D., Mackenzie, N.C., Farquhaarson, C. and Macrae, V.E. (2012) Mechanisms and Clinical Consequences of Vascular Calcification. Frontiers in Endocrinology (Lausanne), 3, 95.
http://dx.doi.org/10.3389/fendo.2012.00095
[22] Wahlqvist, M.L., Tanaka, K. and Tzeng, B.H. (2013) Clinical Decision-Making for Vitamin K-1 and K-2 Deficiency and Coronary Artery Calcification with Warfarin Therapy: Are Diet, Factor Xa Inhibitors or Both the Answer? Asia Pacific Journal of Clinical Nutrition, 22, 492-496.